RxDoctor Payments Data

Matthew Gordon, MD

Orthopaedic Surgery · Boston, MANPI 1417215401

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,344 of the $5,946 with a category attached, or 89.9%. 10 manufacturers reported payments, led by Stryker at 44.0% of the total. Reporting peaked in 2024 at $1,748 and has fallen 51.6% since, to $846 in 2025.

$5,946in general payments, 2019–2025

Across 98 payments — averaging $60.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Zimmer Biomet$1K
  • Smith+Nephew$1K
  • Orthalign Inc$305
  • Globus Medical$203
  • Johnson & Johnson$135
  • plus $299 from 4 others
$5,000in research payments, 2019–2025

Across 2 payments — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$5K

What the payments were for

  • Travel & lodging$60210%
  • Food & beverage$5,34490%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,946 in reported general payments places this provider in the 60th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$150,462
Medicare patients
333
Services billed
1,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin77$514

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →